Clinical Trials Directory

Trials / Completed

CompletedNCT06301178

Effect of Vitamin D Injection on Hypertrophic Scars and Keloids

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Mostafa Bahaa · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Scars and keloids cause patients severe morbidity and psychological distress. Hypertrophic scars rise above the skin but stay within the scar boundaries, while keloids expand. The development of keloids and hypertrophic scars is a consequence of insufficient wound healing. These lesions are distinguished by excessive ECM deposition. Excessive ECM deposition is caused by increased inflammatory and proliferative processes and decreased remodeling activities. These scarring lesions are also linked to genetic and systemic causes

Conditions

Interventions

TypeNameDescription
DRUGCholecalciferolVitamin D has various critical regulatory roles, including inflammatory control, cellular proliferation and differentiation, and wound healing regulation.

Timeline

Start date
2024-02-27
Primary completion
2025-02-20
Completion
2025-02-20
First posted
2024-03-08
Last updated
2025-04-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06301178. Inclusion in this directory is not an endorsement.

Effect of Vitamin D Injection on Hypertrophic Scars and Keloids (NCT06301178) · Clinical Trials Directory